RU2333202C2 - 2-(бутил-1-сульфониламино)-n-[1(r)-(6-метоксипиридин-3-ил)-пропил]бензамид, его применение в качестве лекарственного средства, а также содержащие его фармацевтические композиции - Google Patents
2-(бутил-1-сульфониламино)-n-[1(r)-(6-метоксипиридин-3-ил)-пропил]бензамид, его применение в качестве лекарственного средства, а также содержащие его фармацевтические композиции Download PDFInfo
- Publication number
- RU2333202C2 RU2333202C2 RU2005132163/04A RU2005132163A RU2333202C2 RU 2333202 C2 RU2333202 C2 RU 2333202C2 RU 2005132163/04 A RU2005132163/04 A RU 2005132163/04A RU 2005132163 A RU2005132163 A RU 2005132163A RU 2333202 C2 RU2333202 C2 RU 2333202C2
- Authority
- RU
- Russia
- Prior art keywords
- butyl
- sulfonylamino
- methoxypyridin
- propyl
- benzamide
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10312073A DE10312073A1 (de) | 2003-03-18 | 2003-03-18 | 2-(Butyl-1-sulfonylamino)-N-[1(R)-(6-methoxy-pyridin-3yl)-propyl]-benzamid, dessen Verwendung als Medikament sowie dieses enthaltende pharmazeutische Zubereitungen |
DE10312073.4 | 2003-03-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2005132163A RU2005132163A (ru) | 2006-04-10 |
RU2333202C2 true RU2333202C2 (ru) | 2008-09-10 |
Family
ID=32920928
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2005132163/04A RU2333202C2 (ru) | 2003-03-18 | 2004-03-05 | 2-(бутил-1-сульфониламино)-n-[1(r)-(6-метоксипиридин-3-ил)-пропил]бензамид, его применение в качестве лекарственного средства, а также содержащие его фармацевтические композиции |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP1606237A1 (xx) |
JP (1) | JP2006520343A (xx) |
KR (1) | KR20050110681A (xx) |
CN (1) | CN100361943C (xx) |
AR (1) | AR043622A1 (xx) |
AU (1) | AU2004222137A1 (xx) |
BR (1) | BRPI0408441A (xx) |
CA (1) | CA2519022A1 (xx) |
DE (1) | DE10312073A1 (xx) |
HK (1) | HK1086819A1 (xx) |
HR (1) | HRP20050815A2 (xx) |
MA (1) | MA27749A1 (xx) |
MX (1) | MXPA05009763A (xx) |
MY (1) | MY176510A (xx) |
NO (1) | NO20054472L (xx) |
NZ (1) | NZ542476A (xx) |
PE (1) | PE20050307A1 (xx) |
RS (1) | RS20050690A (xx) |
RU (1) | RU2333202C2 (xx) |
TW (1) | TW200500342A (xx) |
WO (1) | WO2004083157A1 (xx) |
ZA (1) | ZA200506328B (xx) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102004009931A1 (de) * | 2004-02-26 | 2005-09-15 | Aventis Pharma Deutschland Gmbh | Kv1.5-Blocker zur selektiven Steigerung der Vorhofkontraktilität und Behandlung der Herzinsuffizienz |
US7569589B2 (en) | 2004-07-29 | 2009-08-04 | Merck & Co., Inc. | Potassium channel inhibitors |
DE102005028845A1 (de) * | 2005-06-22 | 2006-12-28 | Sanofi-Aventis Deutschland Gmbh | Substituierte Heterocyclen, ihre Verwendung als Medikament sowie enthaltende pharmazeutische Zubereitungen |
JP4943429B2 (ja) * | 2005-07-22 | 2012-05-30 | メルク・シャープ・エンド・ドーム・コーポレイション | カリウムチャネル阻害剤 |
US9101616B2 (en) | 2009-05-29 | 2015-08-11 | Raqualia Pharma Inc. | Aryl substituted carboxamide derivatives as calcium or sodium channel blockers |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10121003A1 (de) * | 2001-04-28 | 2002-12-19 | Aventis Pharma Gmbh | Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
-
2003
- 2003-03-18 DE DE10312073A patent/DE10312073A1/de not_active Withdrawn
-
2004
- 2004-03-05 EP EP04717628A patent/EP1606237A1/de not_active Withdrawn
- 2004-03-05 RS YUP-2005/0690A patent/RS20050690A/sr unknown
- 2004-03-05 PE PE2004000245A patent/PE20050307A1/es not_active Application Discontinuation
- 2004-03-05 KR KR1020057017498A patent/KR20050110681A/ko not_active Application Discontinuation
- 2004-03-05 BR BRPI0408441-1A patent/BRPI0408441A/pt not_active IP Right Cessation
- 2004-03-05 RU RU2005132163/04A patent/RU2333202C2/ru not_active IP Right Cessation
- 2004-03-05 WO PCT/EP2004/002247 patent/WO2004083157A1/de active Application Filing
- 2004-03-05 JP JP2006504553A patent/JP2006520343A/ja not_active Abandoned
- 2004-03-05 NZ NZ542476A patent/NZ542476A/en unknown
- 2004-03-05 CN CNB2004800060168A patent/CN100361943C/zh not_active Expired - Fee Related
- 2004-03-05 CA CA002519022A patent/CA2519022A1/en not_active Abandoned
- 2004-03-05 MX MXPA05009763A patent/MXPA05009763A/es active IP Right Grant
- 2004-03-05 AU AU2004222137A patent/AU2004222137A1/en not_active Abandoned
- 2004-03-16 TW TW093106899A patent/TW200500342A/zh unknown
- 2004-03-16 AR ARP040100866A patent/AR043622A1/es unknown
- 2004-03-17 MY MYPI20040938A patent/MY176510A/en unknown
-
2005
- 2005-08-08 ZA ZA200506328A patent/ZA200506328B/en unknown
- 2005-09-16 HR HR20050815A patent/HRP20050815A2/xx not_active Application Discontinuation
- 2005-09-19 MA MA28502A patent/MA27749A1/fr unknown
- 2005-09-27 NO NO20054472A patent/NO20054472L/no not_active Application Discontinuation
-
2006
- 2006-06-16 HK HK06106891A patent/HK1086819A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ZA200506328B (en) | 2006-04-26 |
AU2004222137A1 (en) | 2004-09-30 |
NO20054472L (no) | 2005-09-27 |
CA2519022A1 (en) | 2004-09-30 |
AR043622A1 (es) | 2005-08-03 |
PE20050307A1 (es) | 2005-06-08 |
RU2005132163A (ru) | 2006-04-10 |
MY176510A (en) | 2020-08-12 |
RS20050690A (sr) | 2008-04-04 |
CN100361943C (zh) | 2008-01-16 |
HRP20050815A2 (en) | 2006-09-30 |
DE10312073A1 (de) | 2004-09-30 |
MXPA05009763A (es) | 2006-01-27 |
BRPI0408441A (pt) | 2006-04-04 |
CN1756728A (zh) | 2006-04-05 |
KR20050110681A (ko) | 2005-11-23 |
MA27749A1 (fr) | 2006-02-01 |
TW200500342A (en) | 2005-01-01 |
HK1086819A1 (en) | 2006-09-29 |
EP1606237A1 (de) | 2005-12-21 |
WO2004083157A1 (de) | 2004-09-30 |
JP2006520343A (ja) | 2006-09-07 |
NZ542476A (en) | 2008-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100548300C (zh) | 雷诺嗪在用于制备治疗心律失常药剂中的应用 | |
EP1385820B1 (de) | Anthranilsäureamide, verfahren zu ihrer herstellung, ihre verwendung als antiarrhythmika sowie pharmazeutische zubereitungen davon | |
RU2275366C2 (ru) | Арилированные амиды фуран- и тиофенкарбоновых кислот с блокирующим калиевый канал действием | |
EP1399423B1 (de) | Anthranilsäureamide mit heteroarylsulfonyl-seitenkette und ihre verwendung als antiarrhythmische wirkstoffe | |
DE60133323T2 (de) | Cardioprotektive Phosphonate | |
WO2002087568A1 (de) | Verwendung von anthranilsäureamiden als medikament zur behandlung von arrhythmien sowie sie enthaltende pharmazeutische zubereitungen | |
DE69917074T2 (de) | Optisch aktives pyridyl-4h-1,2,4-oxadiazinderivat und seine verwendung zur behandlung von gefässkrankheiten | |
CN105792821A (zh) | 包含1-茚满硫酰胺衍生物的疼痛治疗剂和/或预防剂 | |
RU2333202C2 (ru) | 2-(бутил-1-сульфониламино)-n-[1(r)-(6-метоксипиридин-3-ил)-пропил]бензамид, его применение в качестве лекарственного средства, а также содержащие его фармацевтические композиции | |
WO2002045750A1 (fr) | Medicaments combines | |
WO2015192672A1 (zh) | 苯并呋喃类衍生物、其制备方法和应用 | |
CN102001971B (zh) | N-(4-胍基丁基)丁香酰胺衍生物及其医药用途 | |
WO2005084675A1 (de) | Kv1.5-blocker zur selektiven steigerung der vorhofkontraktilität und behandlung der herzinsuffizienz | |
JP7032323B2 (ja) | N-ホルミルペプチド受容体モジュレーターとしてのフェニル尿素誘導体 | |
US20080081926A1 (en) | Sulfonylaminobenzoic acid and salt | |
JP4223237B2 (ja) | 3−フェニル−3,7−ジアザビシクロ[3,3,1]ノナン−化合物、これを含有する医薬品、その使用及びその製法 | |
CN102796092B (zh) | 噁唑烷酮衍生物及其制备方法和应用 | |
EP1670551A1 (de) | Kombination von phenylcarbonsäureamiden mit beta-adrenozeptoren-blockern und deren verwendung zur behandlung von vorhofarrhythmien | |
JPH09118635A (ja) | クラスiiiおよびクラスiv抗不整脈活性を有するジアミン化合物 | |
JPH0662609B2 (ja) | 新規(‐)2‐ピラゾリン化合物及びそれを有効成分とする脳血管障害治療剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20110306 |